

| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $65.5M | +37.5% |
| Cost of Revenue | $23.0M | +17.3% |
| R&D Expense | $17.1M | -41.8% |
| SG&A Expense | $15.0M | +27.7% |
| Operating Income | $10.5M | +180.4% |
| Pre-tax Income | $8.6M | +159.5% |
| Income Tax | $254K | -52.1% |
| Net Income | $8.3M | +155.7% |
| EPS (Basic) | $0.12 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.6M | +38.1% |
| Accounts Receivable | $5.3M | +15.0% |
| Inventory | $19.0M | +13.3% |
| Current Assets | $69.9M | +55.8% |
| Total Assets | $84.4M | +51.4% |
| Current Liabilities | $45.5M | +40.4% |
| Total Liabilities | $50.9M | -23.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.3M | +94.7% |
| Capital Expenditures | $1.1M | +83.0% |
| Investing Cash Flow | -$16.7M | -231.9% |
| Financing Cash Flow | $24.7M | +199.4% |
| Free Cash Flow | -$2.5M | +90.4% |
| +138.7% |
| EPS (Diluted) | $0.09 | +129.0% |
| Stockholders' Equity |
| $33.6M |
| +415.5% |